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Summary 
The hypothesis that cytoplasmic proteases play a functional role in programmed cell death was 
tested by examining the effect of protease inhibitors  on the T  cell receptor-mediated death of 
the 2B4 murine T cell hybridoma and activated T cells. The cysteine protease inhibitors trans- 
epoxysuccininyl-t-leucylamido-(4-guanidino)  butane (E-64) and leupeptin, the calpain selective 
inhibitor  acetyl-leucyl-leucyl-normethional,  and  the  serine  protease  inhibitors  diisopropyl 
fluorophosphate  and phenylmethylsulfonyl fluoride, all showed dose-dependent blocking of the 
2B4 death response triggered by the T cell receptor complex and by anti-Tby-1.  These protease 
inhibitors enhanced rather than inhibited IL-2 secretion triggered by T cell receptor cross-linking, 
showing that they did not act by preventing signal transduction. Growth inhibition induced 
by cross-linking  the 2B4 T cell receptor, measured by inhibition of thymidine incorporation, 
was not generally blocked by these protease inhibitors. All five of these protease inhibitors enhanced 
rather than blocked 2B4 cell death triggered by dexamethasone,  an agent previously shown to 
have a death pathway antagonistic  with that of the TCR. 2B4 cytolysis by the cytotoxic agents 
staphylococcal or-toxin and dodecyl imidazole,  and that caused by hypotonic conditions, was 
not significantly affected by the five protease inhibitors  tested. The selected protease inhibitors 
blocked both the apoptotic nuclear morphology changes and DNA fragmentation induced by 
T cell receptor cross-linking,  and enhanced both these properties induced by dexamethasone in 
2B4 cells. The T cell receptor-induced death of activated murine lymph node T cells and human 
peripheral  blood CD4 + T  cells was blocked by both cysteine and serine protease inhibitors, 
showing that the protease-dependent  death pathway also operates in these systems. 
C 
ell death has become recognized as an important physi- 
ological process in normal development, in hormonal 
regulation of various tissues, and in regulation of the receptor 
repertoires of  both T and B lymphocytes. A major unresolved 
problem is the lack of defined molecular pathways for such 
programmed cell death (PCD). 1 The finding that a pattern 
of morphological changes characterizes  many examples of PCD 
led to the suggestion of a common death mechanism, termed 
apoptosis (1). This concept was extended by the finding that 
1 Abbreviations used in this  paper: AllnM, acetyl-leucine~leucine~normeth- 
ional (Calpain inhibitor II); APNE, acetyl-phenylalanine-B-naphthyl  ester; 
DFP,  diisopropyl  fluorophosphate;  E-64, trans-Epoxysucdninyl-L- 
leucylamido-(4-guanidino)  butane; E-64d, ethyl-trans-Epoxysuccininyl-t- 
leucylamido-3-methylbutane; PCD, programmed  cell death; SEB, 
staphylococcal  enteroto~in  B; TICK, N-tosyl-t-lysine  chloromethyl  ketone; 
TPCK, N-tosyl-L-phenylalanine  chloromethyl ketone. 
nuclear DNA fragmentation correlates well with apoptotic 
morphology (2),  and the current literature contains  many 
examples of PCD accompanied by these features. However, 
the relationship between DNA fragmentation and the mo- 
lecular pathway(s) of cell death has not been meaningfully 
elucidated,  and there are examples of PCD in the absence 
of apoptotic morphology or DNA fragmentation (3, 4). New 
approaches to defining the molecular pathways of PCD are 
dearly needed. 
Lymphocyte-mediated  cytotoxicity has been considered to 
be an example of apoptotic death since the target cells often 
(but not always) show DNA fragmentation (5) and apop- 
totic morphology (6). However, since there is generally no 
requirement for RNA or protein synthesis, this type of cell 
death has been considered to be a different category of apop- 
totic death (7). There is now considerable evidence that the 
effector cell granule proteases known as granzymes induce 
an "internal disintegration" pathway (8) in target cells, leading 
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P. Henkart, manuscript submitted for publication). While 
the above experiments were directed at clarifying the role of 
granzymes in lymphocyte-mediated cytotoxicity, they sug- 
gested a hypothesis that intraceUular protease activation may 
be part of a molecular pathway of PCD. In support of this, 
several distinct serine  protease inhibitors have been shown 
to block TNF-induced cytotoxicity (13-15),  and in some in- 
stances proteolysis has been found to accompany PCD (16, 17). 
To assess the role of intracellular proteases in PCD, we have 
investigated the effects of a variety of protease inhibitors on 
several PCD systems. We describe here studies principally on 
the murine T  cell hybridoma 2B4,  a well-characterized cell 
that responds  to T  cell  receptor cross-linking with PCD 
(18-20).  Similar TCK-induced death has been reported with 
other murine T cell hybridomas (21, 22) and with activated 
peripheral T ceils (23). The present results show that inhibi- 
tors specific for either cysteine or serine proteases  dramati- 
cally block this PCD. Remarkably, the inhibitors do not block 
IL-2 secretion or growth inhibition triggered by the same 
receptor,  indicating that they act on a death-specific molec- 
ular pathway. The active protease inhibitors do not block death 
induced by most other agents, and enhance the death of 2B4 
calls triggered by dexamethasone, previously shown to be 
mediated by an antagonistic PCD pathway (20). 
Materials  and Methods 
Chemicals.  Et  hyl-trans-Epoxysuccininyl-L-leucylamido-3methyl- 
butane (E-64d) was a kind gift of  Dr. K. Hanada, Taisho Phamacen- 
ticals, Saitamo, Japan.  Dodecyl imidazole was purchased from 
Toronto Research Chemicals, Toronto, Canada. Staphylococcal 
c~-toxin  was a gift of  Dr. Sidney  Harshman, Vanderbilt  University. 
Hoechst 33342 was obtained from Molecular Probes, Inc., Eugene, 
OR. Terminal transferase was from Boehringer Mannheim Bin- 
chemicals, Indianapolis, IN, and biotinylated dUTP from Clon- 
tech, Palo Alto, CA. All other chemicals  were from Sigma Chem- 
ical Co., St. Louis, MO. Protease inhibitors were made up as stock 
solutions in dry DMSO at 10 mM (E-64, acetyl-leucine-leucine- 
normethional (ALLnM), and leupeptin) or 100 mM (diisopropyl 
fluorophosphate [DFP], PMSF) and stored at  -20~  and then 
diluted directly into culture medium for use. DMSO controls had 
no measurable effect. 
Cells and PCD Induction.  The 2B4 hybridoma cells used in this 
study are a murine T cell recognizing cytochrome C (24), and were 
a generous gift from Drs. Allan Weissman  and Cristina CenciareUi, 
National Cancer Institute, Bethesda, MD. Mouse lymph node ceils 
were prepared as cell suspensions from axillary lymph nodes of 
C57B1/10 mice. CD4 § human T cells were prepared by exhaus- 
tive negative immunomagnetic selection from peripheral blood 
mononuclear cells of normal donors. Antibody reactive ceils were 
depleted with immunomagnetic beads and a multiantibody cock- 
tail including antibodies against CD20,  CD16, CDllb,  CD14, 
glycophorin, and CD8,  as described previously (25, 26). The 
resulting preparations were >98%  CD3 +  CD4 + by flow cytom- 
etry. 
Cells were cultured in ILPMI  1640 with 10% FCS, plus 20 U/ml 
Ib2 in the case of activated  lymphocytes.  Activation  of mouse  lymph 
nodes ceils was achieved  by 2 d of culture with immobilized 2Cll 
anti-CD3 antibody (27), prepared by precoating flat-bottomed mi- 
crotiter wells with 20 ~tg/ml purified mAb in 0.1 M NaHCO3 
overnight at 5~  Human CD4 + T lymphocytes were similarly 
activated  by a 2-d incubation with immobilized OKT3. After acti- 
vation, the lymphobhsts were cultured in the presence of IL,2 for 
5-7 d before induction of PCD, which was induced in mouse ceils 
by 18 h of culture on immobilized 2Cll anti-CD3 antibody (28), 
or in the case of human cells, a mixture of pokeweed mitogen 
(PWM) (10/~g/ml)  plus staphylococcal enterotoxin B (SEB) (1 
/~g/rrd) both from Sigma  Chemical  Co., St. Louis,  MO, Cell number 
per well varied with the read-out: 1  x  104 for SlCr assay, 1  x 
10  s for trypan, DNA dyes, and IL-2 secretion, and 4  x  10  s for 
growth inhibition and dye reduction. Unhss stated otherwise, pro- 
tease inhibitors were added to cells at the time of their addition 
to the wells containing immobilized antibody to induce PCD. 
5~Cr Release Assay.  2B4 cells in 5 ml culture medium were la- 
beled by addition  of 300  ~tCi Na2SlCrO7 (Amersham Corp., 
Arlington Heights, IL) for 2 h in a CO2 incubator. The cells were 
then harvested and washed before use in the PCD assay. Sponta- 
neous release for the 12-16-h assays used was 30-45%. 
IL2 Assay.  Culture supernatants were harvested and diluted 
twofold with fresh medium into 96-well plates. CTLL cells (2  x 
104/well) were added and cultured for 24 h, after which 0.5 ~tg 
[3H]thymidine  was added to each well, followed by another 24 h 
of culture. The phtes were harvested on an automated filter har- 
vester and counted, r-Human-Ib2 (Cetus Corp., Berkeley, CA) 
was similarly diluted and used as a standard, and the results given 
as Cetus Ib2 units. 
Growth Inhibition Assay.  The assay  for 2B4 growth inhibition 
was performed as described (19) with 3-6 h of culture followed 
by 1-2 h of [3H]thymidine pulse. 
Apoptotic Morphology and DNA Fragmentation  Assays.  Apoptotic 
nuclear morphology was assessed  by culturing cells  for 15 min with 
5/~g/ml of the DNA staining dye Hoechst 33342, transferring 
them to a sMe, and examining them in the fluoroscence micro- 
scope with appropriate UV/blue filters.  DNA fragmentation in situ 
was assessed by the TdT-mediated  dUFF-biotin nick end labeling 
(TUNEL) technique as described  (29) except that the final staining 
was with 1 ttg/ml PITC-avidin and the slides were read in the 
fluorescence microscope. 
l~esuks 
Effect of Selected Protease Inhibitors on TCR-triggered PCD 
and lL-2 Secretion in 2B4 Cells.  A number ofprotease inhib- 
itors that inhibit candidate activatable intracellular proteases 
were tested for toxicity on 2B4 ceils, and those that were 
nontoxic at what were judged to be effective concentrations 
were tested for their ability to reverse PCD induced by over- 
night culture with immobilized mAb against the TCR com- 
plex, or by the soluble anti-Thy-1 mAb G7. Five such inhib- 
itors showed a potent and consistent ability to prevent this 
PCD. These include three calpain inhibitors: the epoxysuc- 
cinyl compound E-64, the peptide aldehyde analogs leupeptin 
and ALLnM, and the dassical serine protease inhibitors DFP 
and PMSE Fig. 1 shows an experiment in which trypan blue 
was used to assess cell death after 16 h  of culture; all five 
protease inhibitors showed a clear dose-related ability to re- 
verse death induced by both immob'dized c~-CD3 and c~-Thy-1, 
at inhibitor concentrations having minimal effect on the via- 
bility of unstimulated control cells. The most potent inhib- 
itor of both anti-Thy-1- and anti-CD3-induced cell death 
was the calpain selective inhibitor ALLnM, which showed 
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Figure  1.  Effect  of  selected  protease  inhibitors  on 
ot-CD3 and anti-Thy-l-induced programmed cell death 
in 284 cells. Cultures of 105 2B4 cells in 200 #1 medium 
were set up in flat-bottomed 96-well plates containing im- 
mobilized anti-CD3 (filled rectangles), anti-Thy-1 mAb G7 
at 5 #g/ml (triangles), or control wells (open rectangles). 
Various protease inhibitors  were added at the initiation 
of culture  to  the  final  concentration  indicated.  After 
16 h of culture, cell viability was assessed with trypan blue. 
maximal inhibition of death in the 25-50 #M range. How- 
ever, higher concentrations of this compound were clearly 
toxic, as seen by their increase in trypan blue staining of un- 
stimulated 2B4 cells. The cysteine protease inhibitors E-64 
and leupeptin also showed a potent ability to reverse PCD, 
giving maximal effects at 50-100/~M.  The serine protease 
inhibitors DFP and PMSF also reversed this death, but only 
concentrations >500 #M achieved a maximal effect. All these 
protease inhibitors gave greater inhibition of ot-Thy-l-induced 
death than ot-CD3-induced death. Similar results were ob- 
tained using mitochondrial dye reduction to assess viability 
after  the overnight culture (data not shown). 
Protease Inhibitors Generally Do Not Block Other TCR-triggered 
Functions in  2B4  Cells.  One possible explanation of the 
blocking of cell death by the protease inhibitors is that they 
interfere with early events in the TCK signal transduction 
pathway, although this has not been previously reported with 
the inhibitors used. To test for this, IL-2 secretion was mea- 
sured by assaying the culture supernatants after an overnight 
culture. As shown in Fig. 2, IL-2 secretion triggered by im- 
mobilized antibody to TCK ~ was generally increased by the 
protease inhibitors showing reversal of cell death. In some 
cases as much as a threefold enhancement was seen in this 
experiment (with ALLnM), and in other experiments as much 
as a sevenfold enhancement was seen (also with ALLnM; data 
not shown). Since the TCK stimulus triggers both death and 
IL-2 secretion within 16 h, blocking cell death selectively 
may be expected to enhance IL-2 secretion. 
It has been shown previously that 2B4 cells respond to 
TCR cross-linking by growth inhibition as measured by the 
early inhibition of [3H]thymidine incorporation. This re- 
sponse is distinct from cell death in that it is not calcium 
dependent or inhibited by cyclosporin A (19). Fig. 3 shows 
that the selected protease inhibitors generally have a minimal 
or negligible effect on this growth inhibition response. The 
experiment shown was pulsed with thymidine after 6 h of 
incubation with antibodies. Other experiments in which the 
cultures were pulsed after 3 h gave similar results.  There is 
some reduction (0-30%) in the level of control thymidine 
incorporation by several of the protease inhibitors, which com- 
plicates the interpretation of these experiments. Leupeptin 
reproducibly showed a partial restoration (20-35%) of the 
growth inhibition as seen Fig. 3, and PMSF showed a vari- 
able degree of partial restoration of thymidine incorporation. 
The other inhibitors showed little or no tendency to restore 
this response to TCR cross-linking, in contrast to the cell 
death response. These data thus reinforce the view that growth 
inhibition,  measured by  thymidine incorporation within 
6 h of TCR cross-linking, involves a pathway that diverges 
from that responsible for cell death. 
Protease Inhibitors That Block 2B4 TCR-induced Cell Death 
Do Not Block Cell Death Induced by Other Agents.  In addi- 
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Figure  2.  Effect of protease  inhibitors  on TCR- 
induced programmed cell death and IL-2 secretion in 
2B4 cells. Cultures were established  as described in 
Fig.  1,  with  immobilized anti-TCR3 (triangles) or 
without stimulation (rectangles). At the end of 16 h, 
supernatants were harvested for assay of IL-2 (solidlines) 
and the cell viability was assessed with trypan blue 
(~shed lines). 
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Figure 3.  Effect  ofprotease inhibitors on T cell receptor-mediated  growth 
inhibition. 2B4 cells (20,000 per well) were cultured on flat bottom micro 
wells coated with immobilized H57 (solid bars) or control wells (striped 
ban) for 6 h, after which each well was pulsed with 1 tzc of [3H]thymi- 
dine for 1.5 h before harvest.  The partial restoration  by PMSF seen in 
this experiment  was not reproduced in other experiments. 
tion to antibodies against the TCR complex and Thy-1, cor- 
ticosteroids have been shown to induce programmed cell death 
in 2B4 cells (20). Fig. 4 shows 51Cr release experiments to 
test whether the selected protease inhibitors blocked PCD 
induced by dexamethasone, a synthetic corticosteroid. While 
the protease inhibitors showed the expected blocking of PCD 
triggered by the TCR or Thy-1, death induced by dexameth- 
asone was modestly but dearly enhanced by all five of the 
protease  inhibitors in a dose-dependent response (Fig.  4). 
StCr release was not induced by the protease inhibitors alone 
at the concentrations used. The enhancement of corticosteroid- 
induced death occurred with both low and high levels of 
steroid-induced PCD  as  shown by  the  two  experiments 
depicted in Fig. 4. Thus, the two antagonistic pathways giving 
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Figure 4.  Effect  of protease inhibitors on 2]34 programmed  cell death 
induced by the TCR, Tby-1, and corticosteroid.  SlCr-labeled 2B4 cells 
were cultured overnight  with the indicated stimuli, and the s~Cr label 
released into the supernatant measured. Triangles represent cultures con- 
taining dexamethasone (2.5  x  10 -6 M), and open rectangles control cul- 
tures with medium only. Representative panels from two separate experi- 
ments are shown here. Filled rectangles show stimulation by oeThy-1 (5 
/zg/ml) in the E-64, PMSF, and DFP panels, and by immobilized o~CD3 
(2(211) in the ALLnM and leupeptin panels. The spontaneous releases were 
54% in the former  experiment  and 35% in the latter. 
PCD in 2B4 are influenced in opposite directions by the pro- 
tease inhibitors. 
The effect of protease inhibitors on a number of other cyto- 
toxic agents and conditions applied to 2B4 cells during an 
overnight culture was examined. In these experiments, the 
2B4 cells were pretreated with protease inhibitors for half 
an hour before culture, since the toxic effects might be more 
rapid than the PCD studied previously.  A negligible effect 
was observed with all the inhibitors tested in some cases, such 
as with the membrane pore-forming agent staphylococcal 
ol-toxin  (30) (shown in Fig.  5),  the lysosomotropic deter- 
gent dodecyl imidazole (31), hypotonic conditions (50% 
water/50%  medium) (data  not shown for the last  two). 
Fig. 5 also shows that death induced by some other toxic 
agents can be either enhanced or suppressed by protease in- 
hibitors. Death by the topoisomerase II inhibitor and chemo- 
therapeutic agent etoposide (32) was generally blocked by 
the protease inhibitors, albeit not as completely as that by 
TCR cross-linking. Surprisingly, cell death elicited by so- 
dium azide was blocked by cysteine but not serine protease 
inhibitors (Fig.  5). 
Protease Inhibitors Block TCR-mediated  and Enhance Steroid- 
mediated  A~ptotic Nuclear  Morphology Changes and DNA Frag- 
mentation in 2134 Celk  Fig. 6 shows an experiment that tested 
the effect of protease inhibitors on the apopotic features of 
2B4 PCD. DNA fragmentation was assessed by the recently 
described sensitive TUNEL technique, which measures DNA 
fragmentation in situ by using terminal transferase and bi- 
otinylated dUTP (29), and nuclear morphology was assessed 
by fluorescence  microscopy using the DNA  staining dye 
Hoechst 33342. The results show that both the TCR-induced 
DNA fragmentation and nuclear morphology changes are 
reversed by the protease inhibitors in parallel with their inhi- 
bition of cdl death measured by membrane permeability. Fur- 
thermore, the increased death seen with dexamethasone in 
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Figure 5.  Effect  of protease inhibitors on 2]34 cell death induced by 
various agents. 5tCr-labeled 2B4 cells were precnltured with protease in- 
hibitors for 30 min before addition of the toxic agent. Label release was 
measured after a 13-h incubation. The spontaneous release in this experi- 
ment was 26%. The inhibitor final concentrations used were: E-64, 100 
/~M; ALLnM, 50/~M; DFP, 1 raM; PMSF, 1 raM.  Final concentrations 
of cytotoxic agents were: staphylococcal or-toxin, 5/~g/ml; etoposide, 5 
/~g/ml; NAN3, 1 mg/ml. 
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TCR.-induced  apoptotic nuclear  morphology changes  and  Figure 6. 
DNA fragmentation are blocked  by protease inhibitors.  2B4 cells were 
cultured for 17 h alone (diagonal st@ed bars), on immobilized o~-TCRcxB 
(filled bars) or with 1 x  10-s M dexamethasone (hatched bars), in the pres- 
ence of the protease inhibitors  indicated.  Cells were analyzed for DNA 
fragmentation by the TUNEL technique,  or for nuclear morphology by 
examination  of Hoechst 33342  stained cells. 
the presence of protease inhibitors  is also dearly apoptotic 
by both criteria. Both these read-outs of apoptotic changes 
correlate with each other and with death measured by mem- 
brane integrity. 
The nuclear morphology of 2B4 cells treated with both 
etoposide and sodium azide was clearly apoptotic, while that 
of 2B4 cells treated  with hypotonic shock,  staphylococcal 
or-toxin and dodecyl imidazole was predominantly nonapop- 
totic. Thus the protease inhibitors tended to have either positive 
or negative influences on apoptotic 2B4 deaths, and little or 
no effect on nonapoptotic deaths. 
Protease Inhibitors Block TCR-mediated Cell Death of Acti- 
vated Murine Lymph Node T Cells and Human CD4 + Pe@h- 
eral Blood T Cells.  To test whether the protease-dependent 
TCR-mediated death pathway operates in normal T cells, we 
tested the ability of the selected protease inhibitors  to block 
the death of activated  peripheral T cells  induced by this receptor 
(23) in both mouse and man. After in vitro activation, lym- 
phocytes were cultured in the presence of IL-2 for several  days 
without other stimulation. With murine lymph node cells, 
subsequent exposure to immobilized anti-CD3 induced sub- 
stantial cell death within 1 d, as was the case with 2B4. Fig. 
7 A  shows that this death was blocked by four of the pro- 
tease inhibitors found to block 2B4 death, and other experi- 
ments indicated that DFP also blocks death in this system 
(data not shown). Activated human CD4 + peripheral blood 
T cells die considerably more slowly when cultured on im- 
mobilized  anti-CD3, requiring 3-5 d for death as seen by 
membrane permeability breakdown (33). Following the sug- 
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Figure  7.  TCR-induced death of activated peripheral T cells is blocked 
by protease inhibitors.  A  shows the effects of protease inhibitors  on the 
death of such activated routine lymph node cells after a subsequent culture 
for 18 h on immobilized anti-CD3 (solid bars) or normal wells (open Mrs). 
Results are the means of two experiments,  with death assessed by trypan 
blue exclusion. The final inhibitor concentrations  1 #M were: E-64, 50; 
ALLnM, 12; leupeptin,  50;  PMSF, 500. B shows an experiment  using 
purified human CD4*  peripheral  blood T cells, in which the activated 
cells were cultured for 20 h with a mixture of PWM and SEB (striped 
bars) or without additional activation (stippled bars). The inhibitor concen- 
trations  were the same as in A, except ALLnM was 25 #M and DFP was 
500 #M. In this case, nuclear morphology was assessed by the dye Hoechst 
33342. In the absence of protease inhibitors, propidium iodide stained 1.8% 
of these cells in the control cultures  without stimulation and  19.4%  in 
the cultures  with PWM/SEB. 
gestions of Groux et al. (34), we found that a mixture of 
pokeweed mitogen and the superantigen staphylococcal en- 
terotoxin B induced death in 2 d, although apoptotic nuclear 
morphology  changes were clearly evident after overnight cul- 
ture.  Fig. 7 B shows that the protease inhibitors  active in 
the 2B4 system also gave substantial blocking of these apop- 
totic changes. 
Discussion 
Previous studies of TCR-triggered PCD in 2B4 and other 
murine T cell hybridomas  have shown that it shares many 
properties with other PCD systems. Several  laboratories have 
studied the mechanism of this PCD, but no molecular death 
pathway has been elucidated. IntraceUular signaling associated 
with this response appears generally similar to that seen  with 
activation responses in T  cells (35). The death response is 
blocked by inhibitors  of protein and RNA synthesis (18), 
implying active participation  of the cells in their death.  It 
requires calcium in the external medium (19) and is accom- 
panied by nuclear DNA fragmentation (21) and apoptotic 
morphology (22). Interestingly, recent studies show that the 
TCR-triggered and corticosteroid-triggered PCD pathways 
are antagonistic, since addition of the two lethal stimuli to- 
1697  Satin  et al. gether result in survival (20, 36). The present results provide 
the first evidence that a protease  is one step of the TCR- 
triggered cell death pathway. The clear finding that cysteine 
protease inhibitors do not inhibit IL-2 secretion in these cells 
argues that this protease step is part of a unique death pathway 
that diverges from other signaling pathways associated with 
activation. 
The experiments described were suggested by two sets of 
recent investigations: (a) multiple lines of evidence that granule 
proteases  are  responsible  for  target  DNA  breakdown in 
lymphocyte-mediated cytotoxicity (9-12);  and (b) injection 
of several different proteases into living cells results in cell 
death generally accompanied by apoptotic morphology and 
DNA breakdown (Williams, M., and P. Henkart, manuscripts 
submitted for publication). Thus, in these systems proteases 
seem to have a potent ability to trigger an as yet uncharacter- 
ized internal disintegration process leading to cell death. It 
appears likely that a similar process is triggered by calpain 
and/or a serine protease in the T lymphocyte systems studied 
here. 
In considering candidate intracellular proteases that might 
be activated in response to TCR cross-linking, calpain was 
the most obvious choice among known proteases because of 
its activation by calcium, whose cytoplasmic concentration 
is known to be rapidly increased in T  lymphocytes by ac- 
tivating stimuli (37).  The two purified calpain  isozymes, 
calpain  I  and calpain  II,  become proteolytically active  at 
micromolar and millimolar Ca concentrations, respectively. 
The regulation of their in situ activity is complex, involving 
a calcium-dependent interaction with the endogenous inhibi- 
tory protein calpastatin,  proteolytic processing,  and interac- 
tion with membranes (38).  Lymphocytes have the highest 
levels of both calpains I and II of any cells measured (39). 
The conclusion that calpain or another cysteine protease 
is part of the PCD pathway in the cells studied here rests 
on the specificity of the inhibitors used. Leupeptin, ALLnM, 
and E-64 do not react  generally with protein -SH groups, 
but are peptide analogs that are bound at the active site of 
the proteases before formation of an adduct with the active 
site cysteine. Calpains are efficiently inhibited by all three of 
these compounds (40). The possibility of reaction with non- 
cysteine protease molecules is unlikely because similar results 
were obtained using different reagents with two different types 
of reactive groups. E-64 (an epoxysuccinyl peptide analogue) 
and leupeptin (a peptide aldehyde) have been characterized 
as reagents specific for cysteine proteases generally including 
lysosomal cathepsins.  While the peptide aldehyde ALLnM 
is highly selective for calpain,  it does react with other cys- 
teine proteases such as papain at a >10x  lower rate, and the 
possibility that it reacts with another cysteine protease in the 
death pathway cannot be ruled out. Thus the data presented 
here  strongly implicate a  cysteine  protease  in  the  TCR- 
mediated cell death of 2B4 and activated T cells, and specifically 
suggest a role for calpain.  Further work is in progress to 
confirm intracellular calpain activation subsequent to TCR 
cross-linking. 
It is interesting to note that calpains have been shown to 
digest cytoskeletal proteins such as spectrin and actin-binding 
protein involved with membrane interactions (41, 42). Thus 
calpain activation has been implicated in the formation of 
membrane blebs (43, 44), which have been regarded as a char- 
acteristic  morphological property of apoptosis (45). 
Since neither calpain nor other cysteine proteases are likely 
to be significantly inhibited by DFP and PMSF, it is possible 
that the TCR-triggered death pathway consists  of at least 
two proteolytic steps, involving a serine protease in addition 
to the E-64-sensitive  step. Such a cytoplasmic protease cas- 
cade has not been previously described, but an obvious specu- 
lation would be that TCR cross-linking elevates Cal which 
activates calpain, which in turn cleaves a serine protease proen- 
zyme. Nevertheless,  the involvement of a serine protease is 
less strongly implicated by the evidence presented here than 
that of a cysteine protease.  First, the inhibitors used, PMSF 
and DFP, are known to react with other enzymes in some 
instances. Second, Fig. 3 shows that PMSF inhibits IL-2 secre- 
tion at high concentrations, in accord with previous results 
showing that it inhibits the TCR-induced Cai increase in 
Jurkat  (46).  N-tosyl-L-phenylalanine  chloromethyl ketone 
(TPCK) also appears to react with the functional molecule 
in this system, suggested to be a 42-kD serine protease (47). 
(TPCK is, however, very toxic to 2B4 cells.) Further experi- 
ments are in progress with other serine protease inhibitors 
to confirm the tentative interpretation that such a protease 
is involved. 
The cell death induced by TNF, which is apoptotic with 
some targets but not others (48), also appears to require pro- 
teolysis. In this case, the functional proteases may be different 
from those in 2B4, as the most effective small molecule in- 
hibitors of TNF cytotoxicity, TPCK, N-tosyl-L-lysine chlo- 
romethyl ketone (TICK), and acetyl-phenylalanine-fl-naphthyl 
ester (APNE) (13, 14), failed to inhibit TCR mediated cell 
death of 2B4 at nontoxic concentrations (data not shown). 
Expression  of endogenous plasminogen activator  type  2 
(PAI-2, a serpin family protease inhibitor) is induced by TNF 
in several targets, and it has been proposed that its expression 
explains why TNF cytotoxicity often requires RNA or pro- 
tein synthesis inhibitors (15). Cells expressing high levels of 
PAI-2 after transfection with its cDNA are resistant to TNF, 
and selection of TNF-resistant variants results  in increased 
expression  of PAI-2 (15). Curiously, the PAI-2 gene is the 
closest mapped locus to the gene for bcl-2, a potent antagonist 
of many examples of cell death (but the two genes are 600 
kb apart)  (49). 
A role for proteases in other systems of PCD has been con- 
sidered by several laboratories. Since leupeptin failed to block 
corticosteroid-induced  death of thymocytes, it was concluded 
that calpain was not involved in this mechanism (50), a finding 
compatible with our results with corticosteroid-induced death 
of 2B4 cells (Fig. 4). More recently it has been shown that 
the serine protease inhibitors TPCK and TLCK block thymo- 
cyte or HL60 cell DNA fragmentation triggered by steroid 
or topoisomerase inhibitors (51, 52). In the HL60 cells, pro- 
teolysis of nuclear proteins accompanies PCD induced by 
etoposide (17). However, in none of these cases was it clear 
that cell death as assessed by nonnudear criteria was reversed 
by protease inhibitors, and the role of proteases in these PCD 
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our laboratory to evaluate the role of proteases in other PCD 
systems. Although these results will be described fully else- 
where, they show that most PCD systems are not blocked 
by cysteine protease inhibitors (Sarin,  A., and P. Henkart, 
manuscript  in  preparation).  Thus  it  appears  that  PCD 
mechanistic pathways are varied, as implied by the differences 
between steroid- and TCR-triggered PCD pathways in 2B4. 
The  protease-dependent  death  pathway described  here 
operates in activated T cells as well as the T cell hybridoma 
line 2B4. Control of this death pathway appears critical for 
regulation of immune responses  after the initial encounter 
with antigen (23). In addition the systems studied here can 
be considered to be a model for two different immunological 
phenomena important for different reasons:  (a)  the TCR- 
triggered PCD that deletes both immature autoreactive thymo- 
cytes (53); and (b) the activation-induced PCD of T cells in 
HIV-infected asymptomatic individuals (34). We have found 
that protease inhibitors inhibit the latter system (Satin, A., 
M. Clerici, S. Blatt, C. Hendrix, G. Sharer, and P. Henkart, 
manuscript submitted for publication). If this PCD plays a 
significant role in HIV pathogenesis, calpain inhibitors may 
provide a novel therapeutic approach to HIV infection. 
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